India Share Brokers | Equity Trading India | Derivative Trading in India | Share Brokers in India

Markets Navigation

Company Info.

Biocon Ltd.

Balance Sheet - Consolidated

Market Cap.(`)	36642.31 Cr.	P/BV	2.05	Book Value (`)	148.81
52 Week High/Low ( ` )	315/218	FV/ML	5/1	P/E(X)	79.20
Book Closure	07/07/2023	EPS (`)	3.85	Div Yield (%)	0.49

(` in Crs.)

You can view the Consolidated Balance Sheet for the last 5 years.

Particulars	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	5.00	5.00	5.00	5.00	5.00
No. of Equity Shares (in Lacs)	12006.00	12006.00	12000.00	12000.00	6000.00

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	600.30	600.30	600.00	600.00	300.00
Total Share Capital	600.30	600.30	600.00	600.00	300.00

Revaluation Reserves	0.90	0.90	0.90	0.90	0.90
Reserves and Surplus	17265.70	7831.30	6930.10	6104.90	5797.10
Total Reserves and Surplus	17266.60	7832.20	6931.00	6105.80	5798.00
Total Shareholders Funds	17866.90	8432.50	7531.00	6705.80	6098.00
Hybrid/Debt/Other Securities	0.00	0.00	95.90	0.00	0.00
Minority Interest	4621.90	1037.50	880.70	677.30	608.90

NON-CURRENT LIABILITIES
Long Term Borrowings	15290.50	3998.50	2961.60	1222.20	1525.60
Deferred Tax Liabilities [Net]	381.80	52.30	32.30	29.80	0.00
Other Long Term Liabilities	5144.50	2953.50	2704.50	1714.90	855.30
Long Term Provisions	226.50	91.70	106.20	85.80	66.10
Total Non-Current Liabilities	21043.30	7096.00	5804.60	3052.70	2447.00

CURRENT LIABILITIES
Short Term Borrowings	2480.20	905.50	594.20	667.60	261.20
Trade Payables	3983.10	1608.50	1513.90	1325.10	1198.30
Other Current Liabilities	1898.80	1183.50	1992.60	1912.30	1498.50
Short Term Provisions	148.60	130.50	109.40	103.00	80.50
Total Current Liabilities	8510.70	3828.00	4210.10	4008.00	3038.50

Total Capital And Liabilities	52042.80	20394.00	18522.30	14443.80	12192.40

ASSETS
NON-CURRENT ASSETS
Tangible Assets	7535.10	5944.00	5710.60	5521.50	4252.70
Intangible Assets	5796.40	598.60	626.90	423.20	191.90
Capital Work-In-Progress	2587.50	3420.30	2253.50	1576.50	1286.90
Intangible Assets Under Development	4729.50	690.10	546.70	619.50	612.00
Fixed Assets	20648.50	10653.00	9137.70	8140.70	6343.50
Goodwill On Consolidation	16136.20	26.40	26.40	26.40	26.40
Non-Current Investments	742.30	370.20	743.20	108.50	182.50
Deferred Tax Assets [Net]	301.00	293.30	307.70	368.00	324.70
Other Non-Current Assets	1880.80	668.80	706.90	475.20	426.80
Total Non-Current Assets	39708.80	12011.70	10921.90	9118.80	7303.90


CURRENT ASSETS
Current Investments	1326.50	1217.70	1208.70	857.60	829.30
Inventories	4243.70	2298.20	1866.60	1435.90	1031.60
Trade Receivables	3573.20	2058.20	1217.60	1223.70	1291.80
Cash And Cash Equivalents	2400.10	1747.50	2015.40	998.60	1057.20
OtherCurrentAssets	790.50	1060.70	1292.10	809.20	678.60
Total Current Assets	12334.00	8382.30	7600.40	5325.00	4888.50

Total Assets	52042.80	20394.00	18522.30	14443.80	12192.40

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	1990.90	1585.00	1588.60	1489.90	1600.60

BONUS DETAILS
Bonus Equity Share Capital	593.47	593.47	593.47	593.47	293.47

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	592.70	303.90	436.20	38.20	0.20

CURRENT INVESTMENTS
Current Investments Quoted Market Value	444.30	251.80	623.70	56.30	119.30
Current Investments Unquoted Book Value	882.20	965.90	585.00	801.30	710.00

Biocon Ltd.

Ratio Analysis - Consolidated

Market Cap.(`)	36642.31 Cr.	P/BV	2.05	Book Value (`)	148.81
52 Week High/Low ( ` )	315/218	FV/ML	5/1	P/E(X)	79.20
Book Closure	07/07/2023	EPS (`)	3.85	Div Yield (%)	0.49

You can view the Consolidated Ratio Analysis for the last 5 years.

Particulars	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	5.00	5.00	5.00	5.00	5.00

PER SHARE RATIOS

Basic EPS (Rs.)	3.88	5.44	6.24	6.32	7.65
Diluted EPS (Rs.)	3.87	5.42	6.19	6.30	7.60
Cash EPS (Rs.)	16.02	14.93	13.59	11.86	24.16
Book Value[Excl.RevalReserv]/Share (Rs.)	187.31	78.87	70.09	61.52	111.77
Book Value[Incl.RevalReserv]/Share (Rs.)	187.31	78.88	70.10	61.53	111.78
Revenue From Operations / Share (Rs.)	93.07	68.17	59.22	52.50	91.91
PBDIT / Share (Rs.)	24.05	18.18	15.89	14.70	25.64
PBIT / Share (Rs.)	14.78	11.40	9.93	10.10	18.17
PBT / Share (Rs.)	8.86	9.91	9.56	10.12	20.23
Net Profit / Share (Rs.)	6.75	8.15	7.63	7.26	16.70
NP After MI And SOA / Share (Rs.)	3.85	5.40	6.17	6.24	15.09

PROFITABILITY RATIOS

PBDIT Margin (%)	25.84	26.67	26.83	28.00	27.89
PBIT Margin (%)	15.88	16.72	16.77	19.24	19.77
PBT Margin (%)	9.52	14.54	16.14	19.28	22.01
Net Profit Margin (%)	7.24	11.95	12.88	13.82	18.16
NP After MI And SOA Margin (%)	4.14	7.92	10.42	11.87	16.41
Return on Networth / Equity (%)	2.58	7.69	9.83	11.15	14.84
Return on Capital Employeed (%)	4.07	8.26	8.32	11.61	11.91
Return On Assets (%)	0.88	3.17	3.99	5.18	7.42
Long Term Debt / Equity (X)	0.85	0.47	0.39	0.18	0.25
Total Debt / Equity (X)	0.99	0.58	0.47	0.28	0.29
Asset Turnover Ratio (%)	0.11	0.12	0.17	0.19	0.31

LIQUIDITY RATIOS

Current Ratio (X)	1.45	2.19	1.81	1.33	1.61
Quick Ratio (X)	0.95	1.59	1.36	0.97	1.27
Inventory Turnover Ratio (X)	0.68	0.75	0.81	1.10	1.68
Dividend Payout Ratio (NP) (%)	12.96	0.00	0.00	8.42	7.97
Dividend Payout Ratio (CP) (%)	3.80	0.00	0.00	4.84	5.33
Earning Retention Ratio (%)	87.04	0.00	0.00	91.58	92.03
Cash Earning Retention Ratio (%)	96.20	0.00	0.00	95.16	94.67

COVERAGE RATIOS

Interest Coverage Ratio (%)	6.89	32.29	33.05	27.19	21.69
Interest Coverage Ratio (Post Tax) (%)	3.63	17.12	16.82	13.82	12.38

VALUATION RATIOS

Enterprise Value (Cr.)	44766.88	44360.07	51477.10	34040.50	37998.50
EV / Net Operating Revenue (X)	4.01	5.42	7.24	5.40	6.89
EV / EBITDA (X)	15.50	20.32	26.99	19.29	24.70
MarketCap / Net Operating Revenue (X)	2.22	4.91	6.90	5.15	6.65
Retention Ratios (%)	87.03	0.00	0.00	91.57	92.02
Price / BV (X)	1.39	4.76	6.51	4.84	6.01
Price / Net Operating Revenue (X)	2.22	4.91	6.90	5.15	6.65
EarningsYield	0.01	0.01	0.01	0.02	0.02

Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. | | ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors" | ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600 | For any Grievance mail to : grievance@sharewealthindia.com | For any DP Grievance mail to : dpgrievance@sharewealthindia.com. | Grievance with SEBI : https://scores.gov.in/scores/Welcome.html

Share Wealth

Biocon Ltd.

Balance Sheet - Consolidated

Biocon Ltd.

Ratio Analysis - Consolidated